Hyperglycemia Induced by Glucokinase Deficiency Accelerates Atherosclerosis Development and Impairs Lesion Regression in Combined Heterozygous Glucokinase and the Apolipoprotein E-Knockout Mice
Open Access
- 28 September 2016
- journal article
- research article
- Published by Wiley in Journal of Diabetes Research
- Vol. 2016, 1-11
Abstract
Aim. Models combining diabetes and atherosclerosis are important in evaluating the cardiovascular (CV) effects and safety of antidiabetes drugs in the development of treatments targeting CV complications. Our aim was to evaluate if crossing the heterozygous glucokinase knockout mouse (GK+/−) and hyperlipidemic mouse deficient in apolipoprotein E (ApoE−/−) will generate a disease model exhibiting a diabetic and macrovascular phenotype.Methods. The effects of defective glucokinase on the glucose metabolism and on the progression and regression of atherosclerosis on high-fat diets were studied in both genders of GK+/−ApoE−/−and ApoE−/−mice. Coronary vascular function of the female GK+/−ApoE−/−and ApoE−/−mice was also investigated.Results. GK+/−ApoE−/−mice show a stable hyperglycemia which was increased on Western diet. In oral glucose tolerance test, GK+/−ApoE−/−mice showed significant glucose intolerance and impaired glucose-stimulated insulin secretion. Plasma lipids were comparable with ApoE−/−mice; nevertheless the GK+/−ApoE−/−mice showed slightly increased atherosclerosis development.Conclusions. The GK+/−ApoE−/−mice showed a stable and reproducible hyperglycemia, accelerated atherosclerotic lesion progression, and no lesion regression after lipid lowering. This novel model provides a promising tool for drug discovery, enabling the evaluation of compound effects against both diabetic and cardiovascular endpoints simultaneously in one animal model.Keywords
This publication has 36 references indexed in Scilit:
- Beta Cell Dysfunction and Insulin ResistanceFrontiers in Endocrinology, 2013
- The use of animal models in diabetes researchBritish Journal of Pharmacology, 2012
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participantsThe Lancet, 2011
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyondJournal of Lipid Research, 2009
- Effect of high‐fat diet on glucose homeostasis and gene expression in glucokinase knockout miceDiabetes, Obesity and Metabolism, 2008
- Effects of Isoflurane on Coronary Blood Flow Velocity in Young, Old and ApoE−/− Mice Measured by Doppler UltrasoundUltrasound in Medicine & Biology, 2007
- Glucokinase and IRS-2 are required for compensatory cell hyperplasia in response to high-fat diet-induced insulin resistanceJournal of Clinical Investigation, 2007
- Liver Glucokinase: Decreased Activity in Patients with Type II DiabetesHormone and Metabolic Research, 1995
- Can lifestyle changes reverse coronary heart disease?The Lancet, 1990